Trial of Regeneron's Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients

Regeneron Pharmaceuticals suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with advanced disease.